What is the treatment regimen for bacterial vaginosis (BV) using metronidazole (Metro) gel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole Gel for Bacterial Vaginosis

For bacterial vaginosis, use metronidazole gel 0.75%, one full applicator (5 grams) intravaginally twice daily for 5 days, which achieves cure rates of 75-87% and is equivalent in efficacy to oral metronidazole while causing fewer gastrointestinal side effects. 1, 2, 3

Standard Treatment Regimen

The FDA-approved dosing is one applicator (5 grams containing 37.5 mg metronidazole) intravaginally either once or twice daily for 5 days 3:

  • Twice-daily dosing: One applicator morning and evening for 5 days 1, 2, 3
  • Once-daily dosing: One applicator at bedtime for 5 days (equivalent efficacy to twice-daily) 3, 4

The twice-daily regimen achieves clinical cure in 75-87% of patients at 7-10 days post-treatment, with sustained cure rates of 58-71% at one month 1, 5, 6. Once-daily dosing yields comparable results: 77% cure at first follow-up and 58% at one month 4.

Critical Patient Counseling

Alcohol avoidance: Patients must avoid all alcohol consumption during treatment and for 24 hours after completion to prevent disulfiram-like reactions (flushing, nausea, vomiting, headache) 1, 7, 2, 8.

Barrier contraception warning: The gel is oil-based and may weaken latex condoms and diaphragms during the treatment period 1, 7, 2.

Allergy consideration: Patients with known allergy to oral metronidazole should NOT receive the vaginal formulation 1, 2.

When to Use Gel vs. Oral Therapy

Metronidazole gel is preferred over oral metronidazole when 1, 6, 9:

  • Patient cannot tolerate systemic side effects (gastrointestinal upset occurs in 52% with oral vs. 33% with gel) 6
  • Patient prefers to avoid systemic medication exposure (peak serum levels with gel are <2% of oral doses) 1
  • Patient has intolerance (but not allergy) to oral metronidazole 1

However, oral metronidazole 500 mg twice daily for 7 days remains the primary recommended regimen and achieves slightly higher cure rates (84-95%) 1, 8.

Common Pitfalls to Avoid

Do NOT treat sex partners: Clinical trials consistently show that treating male partners does not influence cure rates or prevent recurrence 1, 7, 2, 8. Partner treatment is not recommended 1.

Do NOT use gel for trichomoniasis: Metronidazole gel achieves inadequate therapeutic levels in the urethra and perivaginal glands, making it ineffective for trichomonas (<50% efficacy) 1, 2. Only oral metronidazole should be used for trichomoniasis 1.

Do NOT use single-dose regimens for recurrent BV: The 2-gram single oral dose has lower efficacy (84% vs. 95% for multi-day regimens) and should be avoided in recurrent cases 7, 2, 8.

Pregnancy Considerations

Avoid metronidazole gel in pregnancy: The CDC recommends systemic therapy for pregnant women to treat possible subclinical upper genital tract infections 1. For symptomatic low-risk pregnant women, metronidazole gel 0.75% twice daily for 5 days is listed as an alternative, but oral therapy is preferred 1.

For high-risk pregnant women (prior preterm delivery), use metronidazole 250 mg orally three times daily for 7 days in the second trimester 1, 7.

Follow-Up and Recurrence

Follow-up visits are unnecessary if symptoms resolve 1, 2, 8. However, recurrence is common (42-50% within one year) 4, 10, 5.

For recurrent BV after initial treatment failure 10:

  • Extended oral metronidazole: 500 mg twice daily for 10-14 days
  • If still ineffective: Metronidazole gel 0.75% for 10 days, then twice weekly for 3-6 months

No long-term maintenance regimen is recommended for routine cases 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Empiric Treatment of Recurrent Bacterial Vaginosis with Metronidazole Gel

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Recurrent Bacterial Vaginosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metronidazole for Bacterial Vaginosis and E. coli UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Characterization and Treatment of Recurrent Bacterial Vaginosis.

Journal of women's health (2002), 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.